preview

Paper

Decent Essays

Preventative efforts to reduce stress ulcer development include pharmacological agents such as proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RA) (Kersh et al, 2017). The continued use of SUP, such as PPIs, may increase the risk of ventilator-associated pneumonia and Clostridium difficile infections (CDIs) by suppressing gastric acid of bacteriostatic effect (Ro et al, 2016). Because of widespread prophylactic use of pharmacologic agents and the development of hospital-acquired infections (HAIs), healthcare costs have increased by $14,000 per patient (Barletta & Sclar, 2013). Although some evidence suggested that SUP should be implemented for those at increased risk for stress ulcers, it is unclear to whether or not …show more content…

The results showed that the use of SUP in patients with severe sepsis did not have a significantly decreased risk of GI bleeding or an increased risk of CDI. However, the use of SUP in critically ill patients had an increased risk of HAP. As a result, SUP might be unnecessary for patients with severe sepsis. Although there is extensive research concerning the effectiveness of pharmacologic agents of SUP, this study illustrates that prophylactic SUP may lead to adverse outcomes. Nurses can benefit from this practice because it can help prevent complications like HAP when treating patients with severe sepsis. Article Critique Introduction. GI bleeding is a major health concern in patients with severe sepsis, and has been associated with a one to four times increased risk of mortality. SUP, such as PPIs and H2RA, are recommended for patients at risk for GI bleeding. Although severe sepsis is considered a risk factor for GI bleeding, few studies have investigated the effects of SUP in patients with severe sepsis. SUP may be associated with an increased risk of HAP or CDI, therefore this study aimed to investigate the risks and benefits of SUP for patients with severe sepsis. Methods. This study used a retrospective cohort design that included 70,862 patients from 526 acute care hospitals in Japan. The data were collected from the Japanese Diagnosis

Get Access